|Don't panic @ Paul Whiteley|
The paper in question is by Richard Frye and colleagues* (open-access) part of the research tag-team that is Rossignol and Frye discussed in other posts. As a point of interest, the word on the cyberstreet is that Dr Rossignol has started a new programme with autism in mind called MAPS focused on the biomedical aspects of autism (no promotion intended).
Alongside some other quite distinguished names in autism research including Jill James, Dr Frye reports on (a) the prevalence of folate receptor autoantibodies in a group of children diagnosed with an autism spectrum condition, (b) various measures compared with autoantibody negative children with autism and (c) what happens when folinic acid (leucovorin) is given. Folinic acid should not be confused with folic acid which whilst being an essential supplement during pregnancy has had a slightly bumpy ride these past few days following the publication of this meta-analysis.
OK softly, softly catchee monkey.
A good description of cerebral folate deficiency (CFD) syndrome is here. Basically diagnosis is based on low levels of 5-methyltetrahydrofolate (5MTHF) in cerebrospinal fluid (as Wikipedia when not in blackout describes it, the stuff the brain floats in). There are lots of behavioural manifestations of CFD syndrome which aid its description as a neurodevelopmental condition; autism has also been mentioned in some cases of CFD syndrome. Management of CFD syndrome is via the use of folinic acid (leucovorin) to normalise levels of 5MTHF by-passing folate receptors.
Based on the above paragraph coupled with the already suggested link between autism and possible issues with MTHFR (methylentetrahydrofolate reductase) (the enzyme which converts 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, 5MTHF) you can perhaps see why this study was done.
- Ninety-three children (~ 7 years old) diagnosed with autism were screened for folate receptor autoantibodies (FRAs). FRAs are a slightly less invasive way of identifying people who might be at risk of CFD outside of doing a lumbar puncture. The folate receptor is a form of folate binding protein used to transport folate across the blood brain barrier. If you imagine that folate is essential for DNA synthesis, methylation and influences levels of homocysteine, you start to appreciate how important this chap is. FRAs impair the function of the folate receptor which might have knock-on effects similar to more genetically-linked effects on receptors.
- Lots of other information was collected including whether or not participants were following a casein-free (milk-free) diet, given that such diets have been known to reduce FRAs (very, very interesting).
- Looking at both blocking (blocking folate transport) and binding FRAs, 56/93 (60%) of children were positive for blocking FRAs and 41/93 (44%) positive for binding FRAs. Twenty-nine percent of children were positive for both FRAs and 70/93 (75%) positive for at least one FRA. Interestingly, when it came to looking at rates of autoimmune conditions in the family history, more instances were found in those who did not have FRAs than those who did (60% vs. 24%). No other measures significantly differed between positive and negative autoantibody groups (aside from age at testing).
- A lumbar puncture was performed on 16 children included for study and levels of 5-methyltetrahydrofolate were found to be below the normative mean in every case (although not falling below the lower limit of normal though).
- A subgroup of 44 children from the 70 positive for at least one FRA were treated with leucovorin calcium tablets for at least 1 month (mean treatment time was 4 months). Based on parental responses to the Clinical Global Impression Scale - Improvement subscale on various items of cognition and behaviour, approximately two-thirds of children were deemed to have obtained some benefit.
There is a lot of detail to this paper which unfortunately I have neither the time nor space to go through in this post. Allowing for the fact that quite a few inferences were made during the study i.e. the 5MTHF levels found for those who underwent lumbar puncture would also be noted in those who were not tested, combined with the less than impressive way that the clinical effects of folinic acid were reported, there are some valuable details to be had from this report.
The rate of FRAs (blocking and/or binding) noted in the autism group (75%) is high and suggests that quite a bit more study is due in this area not least in comparison to other developmental conditions and control populations. I note for example that studies of blocking FRAs in Rett syndrome suggest that a smaller proportion of this group might be affected (24%). I do also wonder about whether there is any link with the timing of symptom onset, and in particular whether reported regression in behaviour has any effect on the likelihood of FRAs being present or not as per what happens in CFD. Speaking of regression and autism, how about this recent article?
Much like the recent findings from Jyonouchi and colleagues on SPAD and autism, the message yet again is don't stop looking for other things just because a diagnosis of autism is received (bearing in mind that I am not advocating invasive procedures like lumbar puncture unless clinically directed). The potential usefulness of a milk-free diet in cases where FRAs are present also opens up a whole new world of possibilities.
Hopefully you have not panicked and I have not left you dazed and confused with this post. If I have, I apologise; and paying homage to the classic Richard Linklater film Dazed and Confused I offer some light metal relief. Take it away Mr Alice Cooper... (he's such a nice guy).
* Frye RE. et al. Cerebral folate receptor autoantibodies in autism spectrum disorder. Molecular Psychiatry. January 2012.
Hi Paul Whiteley -ReplyDelete
I haven't read this paper yet, but if I understand correctly, this patient cohort wasn't comprised of any old kids with autism, but a lot of so called 'tough nuts'.
There was an earlier CFD paper, "Folate Receptor Autoimmunity and Cerebral
Folate Deﬁciency in Low-Functioning Autism with
Neurological Deﬁcits" [http://www.bh4.org/pdf/ramaekers%20autism%202007.pdf]. This paper also had a cohort of low functioning children, with early onset symptoms, and also matched some other qualifiers.
This paper described some rather amazing results; i.e:
"Two patients (patients 2, 4) who were diagnosed
early and received treatment were cured with full recovery from autism and neurological deﬁcits" (!!)
That isn't the kind of thing you see too often.
The paper is a little vague on how the participant group were spread out aside from saying that DSM-IV was diagnosed and that regression was a factor in roughly half of the group. That said epilepsy was also present in about 40% and quite a few had also been diagnosed with a mitochrondrial disorder.
As per my comment on your last comment(!), the good thing about this and the other papers is that they aren't just assuming that autism is the 'cause' of all these issues, but rather than co-morbidities seem to play a role (and impact on the presentation of autism).
Both my children: 14yo ASD and 12yo NT had blocking AB to Folate Receptor. Both started on Leucovorin. When done right, both had very positive results. ASD child with elimination of auditory processing delays and boost into "typical" social abilities and NT child with boost to overall health and pallor. HOWEVER it's probably important that we've been trying to optimize methylation in both for 4-7+ years. This was the last piece of the puzzle and as a result their detox abilities seem to have normalized and we are getting a flood of toxins eliminated in both. Of course this always lends itself to leftover pathogens so bottom line, it's complicated to do this right but oh my what great results!ReplyDelete
Planning to start supplementation with folonic acid, for my two boys ages 14 and 10. Any suggestions on dose and brand. I am told that 75 percent of autistic children tested, have this deficiency.
Great post! I am doing a project on the association between folate receptor autoantibodies and autism, I had a few questions about this, I would love to get your idea on these.
1. In most of these studies, authors have reported an increased prevalence of FRAA in autistic patients (and their families) but not considered if the plasma levels of FRAA differ significantly between autistic patients and controls. Shouldn't more FRAA be more important than just being positive for FRAA?
2. Also, if these antibodies are also present in normal individuals, why do they not have an effect in the normal population?
3. Considering that the antibodies fluctuate over time, how can a single recording (as in many of these studies) be used to establish who is positive and negative, especially since levels can also go subzero?
4. Finally, the correlation between CSF 5MTHF and FRAA has not been consistently recorded in these studies, shouldn't this be the first step in establishing the utility of the test?
I would really really appreciate any input.